APA (7th ed.) Citation

Shi, Z., Zheng, H., Han, M., Hu, J., Hu, Y., Li, X., . . . Huang, A. (2023). Durability of Hepatitis B surface antigen seroclearance in patients experienced nucleoside analogs or interferon monotherapy: A real-world data from Electronic Health Record. Genes & diseases, 10(3), 1019-1028. https://doi.org/10.1016/j.gendis.2022.03.003

Chicago Style (17th ed.) Citation

Shi, Zongqi, et al. "Durability of Hepatitis B Surface Antigen Seroclearance in Patients Experienced Nucleoside Analogs or Interferon Monotherapy: A Real-world Data from Electronic Health Record." Genes & Diseases 10, no. 3 (2023): 1019-1028. https://doi.org/10.1016/j.gendis.2022.03.003.

MLA (9th ed.) Citation

Shi, Zongqi, et al. "Durability of Hepatitis B Surface Antigen Seroclearance in Patients Experienced Nucleoside Analogs or Interferon Monotherapy: A Real-world Data from Electronic Health Record." Genes & Diseases, vol. 10, no. 3, 2023, pp. 1019-1028, https://doi.org/10.1016/j.gendis.2022.03.003.